These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30914386)

  • 1. Computational screening of potential drug targets for pathogens causing bacterial pneumonia.
    Nayak S; Pradhan D; Singh H; Reddy MS
    Microb Pathog; 2019 May; 130():271-282. PubMed ID: 30914386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA.
    Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS
    Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling novel broad-spectrum antibacterial targets in food and waterborne pathogens using comparative genomics and protein interaction network analysis.
    Jadhav A; Shanmugham B; Rajendiran A; Pan A
    Infect Genet Evol; 2014 Oct; 27():300-8. PubMed ID: 25128740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TiD: Standalone software for mining putative drug targets from bacterial proteome.
    Gupta R; Pradhan D; Jain AK; Rai CS
    Genomics; 2017 Jan; 109(1):51-57. PubMed ID: 27856224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case study.
    Maurya PK; Singh S; Mani A
    Acta Trop; 2018 Jun; 182():100-110. PubMed ID: 29474831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.
    Leesik H; Ani U; Juhani A; Altraja A
    Medicina (Kaunas); 2006; 42(5):384-94. PubMed ID: 16778466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Drug Targets for Food-Borne Pathogen Campylobacter jejuni: An Integrated Subtractive Genomics and Comparative Metabolic Pathway Study.
    Mehla K; Ramana J
    OMICS; 2015 Jul; 19(7):393-406. PubMed ID: 26061459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
    Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
    Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome mining for the identification and in-silico characterization of putative drug targets of multi-drug resistant Clostridium difficile strain 630.
    Lohani M; Dhasmana A; Haque S; Wahid M; Jawed A; Dar SA; Mandal RK; Areeshi MY; Khan S
    J Microbiol Methods; 2017 May; 136():6-10. PubMed ID: 28235560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis.
    Kaur H; Kalia M; Taneja N
    Microb Pathog; 2021 Mar; 152():104608. PubMed ID: 33166618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
    Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
    J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.
    Feldman C; Brink AJ; von Gottberg A; Wolter N; de Gouveia L; Perovic O; Klugman KP
    Int J Antimicrob Agents; 2010 Jul; 36(1):95-7. PubMed ID: 20378315
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against
    Khan K; Jalal K; Khan A; Al-Harrasi A; Uddin R
    Front Microbiol; 2021; 12():796363. PubMed ID: 35222301
    [No Abstract]   [Full Text] [Related]  

  • 18. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
    Seok H; Kang CI; Huh K; Cho SY; Ha YE; Chung DR; Peck KR
    Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis.
    Singh S; Singh DB; Singh A; Gautam B; Ram G; Dwivedi S; Ramteke PW
    Interdiscip Sci; 2016 Dec; 8(4):388-394. PubMed ID: 26750924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.